These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28384010)

  • 1. Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study.
    Strawn JR; Dobson ET; Mills JA; Cornwall GJ; Sakolsky D; Birmaher B; Compton SN; Piacentini J; McCracken JT; Ginsburg GS; Kendall PC; Walkup JT; Albano AM; Rynn MA
    J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):501-508. PubMed ID: 28384010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS.
    Ginsburg GS; Kendall PC; Sakolsky D; Compton SN; Piacentini J; Albano AM; Walkup JT; Sherrill J; Coffey KA; Rynn MA; Keeton CP; McCracken JT; Bergman L; Iyengar S; Birmaher B; March J
    J Consult Clin Psychol; 2011 Dec; 79(6):806-13. PubMed ID: 22122292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS).
    Piacentini J; Bennett S; Compton SN; Kendall PC; Birmaher B; Albano AM; March J; Sherrill J; Sakolsky D; Ginsburg G; Rynn M; Bergman RL; Gosch E; Waslick B; Iyengar S; McCracken J; Walkup J
    J Am Acad Child Adolesc Psychiatry; 2014 Mar; 53(3):297-310. PubMed ID: 24565357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial.
    Compton SN; Peris TS; Almirall D; Birmaher B; Sherrill J; Kendall PC; March JS; Gosch EA; Ginsburg GS; Rynn MA; Piacentini JC; McCracken JT; Keeton CP; Suveg CM; Aschenbrand SG; Sakolsky D; Iyengar S; Walkup JT; Albano AM
    J Consult Clin Psychol; 2014 Apr; 82(2):212-24. PubMed ID: 24417601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of treatment improvement on long-term anxiety: Results from CAMS and CAMELS.
    Crane ME; Norris LA; Frank HE; Klugman J; Ginsburg GS; Keeton C; Albano AM; Piacentini J; Peris TS; Compton SN; Sakolsky D; Birmaher B; Kendall PC
    J Consult Clin Psychol; 2021 Feb; 89(2):126-133. PubMed ID: 33705168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediators of change in the Child/Adolescent Anxiety Multimodal Treatment Study.
    Kendall PC; Cummings CM; Villabø MA; Narayanan MK; Treadwell K; Birmaher B; Compton S; Piacentini J; Sherrill J; Walkup J; Gosch E; Keeton C; Ginsburg G; Suveg C; Albano AM
    J Consult Clin Psychol; 2016 Jan; 84(1):1-14. PubMed ID: 26460572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results from the Child/Adolescent Anxiety Multimodal Longitudinal Study (CAMELS): Functional outcomes.
    Swan AJ; Kendall PC; Olino T; Ginsburg G; Keeton C; Compton S; Piacentini J; Peris T; Sakolsky D; Birmaher B; Albano AM
    J Consult Clin Psychol; 2018 Sep; 86(9):738-750. PubMed ID: 30138013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic complaints in anxious youth.
    Crawley SA; Caporino NE; Birmaher B; Ginsburg G; Piacentini J; Albano AM; Sherrill J; Sakolsky D; Compton SN; Rynn M; McCracken J; Gosch E; Keeton C; March J; Walkup JT; Kendall PC
    Child Psychiatry Hum Dev; 2014 Aug; 45(4):398-407. PubMed ID: 24129543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.
    Walkup JT; Albano AM; Piacentini J; Birmaher B; Compton SN; Sherrill JT; Ginsburg GS; Rynn MA; McCracken J; Waslick B; Iyengar S; March JS; Kendall PC
    N Engl J Med; 2008 Dec; 359(26):2753-66. PubMed ID: 18974308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Development on Antidepressant and Placebo Response in Anxiety Disorders: A Bayesian Hierarchical Meta-Analytic Examination of Randomized Controlled Trials in Children, Adolescents, and Adults.
    Mills JA; Mendez E; Strawn JR
    J Child Adolesc Psychopharmacol; 2024 Sep; 34(7):302-309. PubMed ID: 38800869
    [No Abstract]   [Full Text] [Related]  

  • 11. Benefits of child-focused anxiety treatments for parents and family functioning.
    Keeton CP; Ginsburg GS; Drake KL; Sakolsky D; Kendall PC; Birmaher B; Albano AM; March JS; Rynn M; Piacentini J; Walkup JT
    Depress Anxiety; 2013 Sep; 30(9):865-72. PubMed ID: 23390005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic relationship in cognitive-behavioral therapy and pharmacotherapy for anxious youth.
    Cummings CM; Caporino NE; Settipani CA; Read KL; Compton SN; March J; Sherrill J; Piacentini J; McCracken J; Walkup JT; Ginsburg G; Albano AM; Rynn M; Birmaher B; Sakolsky D; Gosch E; Keeton C; Kendall PC
    J Consult Clin Psychol; 2013 Oct; 81(5):859-64. PubMed ID: 23750468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale.
    Caporino NE; Brodman DM; Kendall PC; Albano AM; Sherrill J; Piacentini J; Sakolsky D; Birmaher B; Compton SN; Ginsburg G; Rynn M; McCracken J; Gosch E; Keeton C; March J; Walkup JT
    J Am Acad Child Adolesc Psychiatry; 2013 Jan; 52(1):57-67. PubMed ID: 23265634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation of Pharmacotherapy Following CBT in Anxious Youth: Results From the Child/Adolescent Anxiety Multimodal Study (CAMS).
    Strawn JR; Mills JA; Rothenberg R; Piacentini J; Peris TS; McCracken JT; Walkup JT
    J Clin Psychiatry; 2022 Dec; 84(1):. PubMed ID: 36479955
    [No Abstract]   [Full Text] [Related]  

  • 15. Mediators of youth anxiety outcomes 3 to 12 years after treatment.
    Makover HB; Kendall PC; Olino T; Carper MM; Albano AM; Piacentini J; Peris T; Langley AK; Gonzalez A; Ginsburg GS; Compton S; Birmaher B; Sakolsky D; Keeton C; Walkup J
    J Anxiety Disord; 2020 Mar; 70():102188. PubMed ID: 32078966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Child/Adolescent anxiety multimodal study: evaluating safety.
    Rynn MA; Walkup JT; Compton SN; Sakolsky DJ; Sherrill JT; Shen S; Kendall PC; McCracken J; Albano AM; Piacentini J; Riddle MA; Keeton C; Waslick B; Chrisman A; Iyengar S; March JS; Birmaher B
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):180-90. PubMed ID: 25721183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results From the Child/Adolescent Anxiety Multimodal Extended Long-Term Study (CAMELS): Primary Anxiety Outcomes.
    Ginsburg GS; Becker-Haimes EM; Keeton C; Kendall PC; Iyengar S; Sakolsky D; Albano AM; Peris T; Compton SN; Piacentini J
    J Am Acad Child Adolesc Psychiatry; 2018 Jul; 57(7):471-480. PubMed ID: 29960692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom-specific effects of cognitive-behavioral therapy, sertraline, and their combination in a large randomized controlled trial of pediatric anxiety disorders.
    Cervin M; Storch EA; Piacentini J; Birmaher B; Compton SN; Albano AM; Gosch E; Walkup JT; Kendall PC
    J Child Psychol Psychiatry; 2020 Apr; 61(4):492-502. PubMed ID: 31471911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing Clinical Cutoffs for Response and Remission on the Screen for Child Anxiety Related Emotional Disorders (SCARED).
    Caporino NE; Sakolsky D; Brodman DM; McGuire JF; Piacentini J; Peris TS; Ginsburg GS; Walkup JT; Iyengar S; Kendall PC; Birmaher B
    J Am Acad Child Adolesc Psychiatry; 2017 Aug; 56(8):696-702. PubMed ID: 28735699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monotherapy Insufficient in Severe Anxiety? Predictors and Moderators in the Child/Adolescent Anxiety Multimodal Study.
    Taylor JH; Lebowitz ER; Jakubovski E; Coughlin CG; Silverman WK; Bloch MH
    J Clin Child Adolesc Psychol; 2018; 47(2):266-281. PubMed ID: 28956620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.